Newsroom | 40208 results

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced the availability of the largest source of novel medical content - with over 33M artifacts of evidence generated by a high-throughput, standardized observational evidence-creation workflow. Alexandria®, the Atropos Evidence™ Library, is slated to grow to two billion pEBFs by the end of 2026, exceeding all known medical evidence by 100x in volu...

BALTIMORE, Md.--(BUSINESS WIRE)--Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST R2 Certified post-acute care analytics solution, announced today its participation in the National Association of ACOs (NAACOS) Spring 2026 Conference, taking place April 22-24, 2026, in Baltimore, MD. As CMS officials and accountable care leaders gather to address evolving policy, operational, and care delivery challenges, Real Time will showcase its AI-driven interventional an...

BOSTON--(BUSINESS WIRE)--AcuityMD, the AI platform for MedTech, today announced $80 million in new funding to elevate its platform with advanced artificial intelligence (AI) capabilities and drive the company’s mission of accelerating adoption of medical technology. The Series C round was led by existing investor StepStone Group, with additional participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. Now supporting 16 of the top 20 MedTech companies and having helped c...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced today that it was granted CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for both its ArteraAI Prostate Biopsy Assay and ArteraAI Breast Cancer Assay, marking a major step in the company’s global expansion. The ArteraAI Prostate Biopsy Assay is the first CE-marked AI-enabled prognostic and predictive in vitro diagnostic (IVD) test for prostat...

INDIANAPOLIS--(BUSINESS WIRE)--Olio and AION Biosystems close the post-discharge blind spot by feeding continuous wearable device data directly into SNF care transition workflows....

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company’s core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and cl...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) has shared the results of a retrospective analysis in Regulatory Toxicology and Pharmacology, showing that virtual control groups (VCGs) can preserve scientific integrity while reducing reliance on animal models. The review, which looked at 20 toxicology studies that replaced concurrent control groups (CCGs) with curated VCGs, and compared the outcomes across study-level decisions and detailed endpoin...

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson showcases CARTO-powered innovation, including debut of CARTOSOUND SONATA, to advance arrhythmia care at HRS 2026...

WORCESTER, England--(BUSINESS WIRE)--A defining achievement has been reached in the evolution of hip preservation technology, the Polymotion® Hip Resurfacing (PHR®) IDE study has officially achieved full enrolment. On Friday, April 3rd, Dr. William Macaulay at NYU Langone performed the final procedure, bringing recruitment to a close and highlighting the growing interest in bone-conserving treatment options for young, active patients. The study began on January 22, 2025, with the first procedur...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing th...